Highlights from the ‘Noncoding RNA world: From Mechanism to Therapy’ conference, July 21-23, 2021

Saadeldin,Mona Kamal

doi:10.3892/wasj.2021.135

Highlights from the ‘Noncoding RNA world: From Mechanism to Therapy’ conference, July 21-23, 2021

Authors:
- Mona Kamal Saadeldin
View Affiliations

Affiliations: Department of Biosciences, University of Milan, I‑20133 Milan, Italy
Published online on: October 20, 2021 https://doi.org/10.3892/wasj.2021.135
Article Number: 64
Copyright: © Saadeldin . This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non‑coding RNAs (ncRNAs) are involved in different cellular processes and some of them are considered to play a role in the development of numerous diseases. The recent discovery of ncRNAs is the result of several experimental and bioinformatics studies. On July 21‑23, 2021, the ‘Noncoding RNA World: From Mechanism to Therapy’ conference that was held virtually (originally planned to be held in Basel, Switzerland), gathered experts and researchers from countries worldwide to cover the latest achievements in ncRNA research, including the basic molecular mechanisms and structural biology, bioinformatics, biotechnology, disease development and therapeutics of ncRNAs. The meeting was dominated by a feeling of satisfaction and enthusiasm for the novel discoveries in the ncRNA field that is considered to be relatively new. Intriguingly, several discoveries are added daily beside numerous hurdles that are encountered or remain to be resolved in order for these findings to be translated into clinical practice.

View Figures

View References

1	Yang Y, Ge H, Li DQ and Xu AX: E2F1-Induced lncRNA BAIAP2-AS1 overexpression contributes to the malignant progression of hepatocellular carcinoma via miR-361-3p/SOX4 axis. Dis Markers. 2021(6256369)2021.PubMed/NCBI View Article : Google Scholar
2	Hinkel R, Batkai S, Bähr A, Bozoglu T, Straub S, Borchert T, Viereck J, Howe A, Hornaschewitz N, Oberberger L, et al: AntimiR-132 attenuates myocardial hypertrophy in an animal model of percutaneous aortic constriction. J Am Coll Cardiol. 77:2923–2935. 2021.PubMed/NCBI View Article : Google Scholar
3	Täubel J, Hauke W, Rump S, Viereck J, Batkai S, Poetzsch J, Rode L, Weigt H, Genschel C, Lorch U, et al: Novel antisense therapy targeting microRNA-132 in patients with heart failure: Results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study. Eur Heart J. 42:178–188. 2021.PubMed/NCBI View Article : Google Scholar
4	Martin SE, Gan H, Toomer G, Sridhar N and Sztuba-Solinska J: The m6A landscape of polyadenylated nuclear (PAN) RNA and its related methylome in the context of KSHV replication. RNA. 27:1102–1125. 2021.PubMed/NCBI View Article : Google Scholar
5	Pereira M, Ribeiro DR, Pinheiro MM, Ferreira M, Kellner S and Soares AR: m ⁵ U54 tRNA Hypomodification by Lack of TRMT2A Drives the Generation of tRNA-Derived Small RNAs. Int J Mol Sci. 22(2941)2021.PubMed/NCBI View Article : Google Scholar
6	Youness RA and Gad MZ: Long non-coding RNAs: Functional regulatory players in breast cancer. Noncoding RNA Res. 4:36–44. 2019.PubMed/NCBI View Article : Google Scholar : Erratum in: Noncoding RNA Res 5: 219, 2020.
7	Kim YK, Kim B and Kim VN: Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis. Proc Natl Acad Sci USA. 113:E1881–E1889. 2016.PubMed/NCBI View Article : Google Scholar
8	Kwon SC, Nguyen TA, Choi YG, Jo MH, Hohng S, Kim VN and Woo JS: Structure of Human DROSHA. Cell. 164:81–90. 2016.PubMed/NCBI View Article : Google Scholar
9	Kim B, Jeong K and Kim VN: Genome-wide Mapping of DROSHA Cleavage Sites on Primary MicroRNAs and Noncanonical Substrates. Mol Cell. 66:258–269.e5. 2017.PubMed/NCBI View Article : Google Scholar
10	Ramilowski JA, Yip CW, Agrawal S, Chang JC, Ciani Y, Kulakovskiy IV, Mendez M, Ooi JLC, Ouyang JF, Parkinson N, et al: Functional annotation of human long noncoding RNAs via molecular phenotyping. Genome Res. 30:1060–1072. 2020.PubMed/NCBI View Article : Google Scholar
11	Moody J, Kouno T, Suzuki A, Shibayama Y, Terao C, Chang JC, López-Redondo F, Yip CW, Ando Y, Yamamoto K, et al: Profiling of transcribed cis-regulatory elements in single cells. bioRxiv: doi: https://doi.org/10.1101/2021.04.04.438388.
12	Saadeldin MK, Abdel-Aziz AK and Abdellatif A: Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis. Med Hypotheses. 146(110365)2021.PubMed/NCBI View Article : Google Scholar
13	Shao W, Bi X, Gao B, Wu J, Pan Y, Yin Y, Liu Z, Zhang W, Jiang X, Ren W, et al: Phase separation of RNA-binding protein promotes polymerase engagement and transcription. bioRxiv: doi: https://doi.org/10.1101/2021.03.26.436939.
14	Nithin C, Ghosh P and Bujnicki JM: Bioinformatics tools and benchmarks for computational docking and 3D structure prediction of RNA-protein complexes. Genes (Basel). 9(432)2018.PubMed/NCBI View Article : Google Scholar
15	Ponce-Salvatierra A, Astha Merdas K, Nithin C, Ghosh P, Mukherjee S and Bujnicki JM: Computational modeling of RNA 3D structure based on experimental data. Biosci Rep. 39(BSR20180430)2019.PubMed/NCBI View Article : Google Scholar
16	Boniecki MJ, Lach G, Dawson WK, Tomala K, Lukasz P, Soltysinski T, Rother KM and Bujnicki JM: SimRNA: A coarse-grained method for RNA folding simulations and 3D structure prediction. Nucleic Acids Res. 44(e63)2016.PubMed/NCBI View Article : Google Scholar
17	Chen H, Egger M, Xu X, Flemmich L, Krasheninina O, Sun A, Micura R and Ren A: Structural distinctions between NAD+ riboswitch domains 1 and 2 determine differential folding and ligand binding. Nucleic Acids Res. 48:12394–12406. 2020.PubMed/NCBI View Article : Google Scholar
18	Ishida K, Miyauchi K, Kimura Y, Mito M, Okada S, Suzuki T and Nakagawa S: Regulation of gene expression via retrotransposon insertions and the noncoding RNA 4.5S RNAH. Genes Cells. 20:887–901. 2015.PubMed/NCBI View Article : Google Scholar
19	Errichelli L, Dini Modigliani S, Laneve P, Colantoni A, Legnini I, Capauto D, Rosa A, De Santis R, Scarfò R, Peruzzi G, et al: FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat Commun. 8(14741)2017.PubMed/NCBI View Article : Google Scholar
20	Gandhi M, Groß M, Holler JM, Coggins SAA, Patil N, Leupold JH, Munschauer M, Schenone M, Hartigan CR, Allgayer H, et al: The lncRNA lincNMR regulates nucleotide metabolism via a YBX1-RRM2 axis in cancer. Nat Commun. 11(3214)2020.PubMed/NCBI View Article : Google Scholar
21	Caudron-Herger M, Rusin SF, Adamo ME, Seiler J, Schmid VK, Barreau E, Kettenbach AN and Diederichs S: R-DeeP: Proteome-wide and Quantitative Identification of RNA-Dependent Proteins by Density Gradient Ultracentrifugation. Mol Cell. 75:184–199.e10. 2019.PubMed/NCBI View Article : Google Scholar
22	Caudron-Herger M, Wassmer E, Nasa I, Schultz A-S, Seiler J, Kettenbach AN and Diederichs S: Identification, quantification and bioinformatic analysis of RNA-dependent proteins by RNase treatment and density gradient ultracentrifugation using R-DeeP. Nat Protoc. 15:1338–1370. 2020.PubMed/NCBI View Article : Google Scholar
23	Zhu S, Li W, Liu J, Chen CH, Liao Q, Xu P, Xu H, Xiao T, Cao Z, Peng J, et al: Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nat Biotechnol. 34:1279–1286. 2016.PubMed/NCBI View Article : Google Scholar
24	Qu L, Yi Z, Zhu S, Wang C, Cao Z, Zhou Z, Yuan P, Yu Y, Tian F, Liu Z, et al: Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs. Nat Biotechnol. 37:1059–1069. 2019.PubMed/NCBI View Article : Google Scholar : Erratum in: Nat Biotechnol 37: 1380, 2019.
25	Tichon A, Perry RBT, Stojic L and Ulitsky I: SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA. Genes Dev. 32:70–78. 2018.PubMed/NCBI View Article : Google Scholar